Concepedia

Nikoletta Lendvai

NL

61

Publications

4.6K

Citations

34

H-Index

1998

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Janssen (United States)

Dana-Farber Cancer Institute

Medical College of Wisconsin

Nikoletta Lendvai is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1998–2025

61

Publications

61

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · The Lancet Oncology · 2019 · 772 citations

, , +6

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesús F. San Miguel, Binod Dhakal, Kwee Yong et al. · New England Journal of Medicine · 2023 · 615 citations · Full text

Characterization of a Murine Monoclonal Antibody to<i>Cryptococcus neoformans</i>Polysaccharide That Is a Candidate for Human Therapeutic Studies

Arturo Casadevall, Wendy Cleare, Marta Feldmesser et al. · Antimicrobial Agents and Chemotherapy · 1998 · 303 citations · Full text

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat et al. · The Lancet Oncology · 2018 · 235 citations

, , +7

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Adam D. Cohen, Samir Parekh, Bianca Santomasso et al. · Blood Cancer Journal · 2022 · 235 citations · Full text

Rows per page

1–5 of 61